CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy.
Tuscano JM, Kato J, Pearson D, Xiong C, Newell L, Ma Y, Gandara DR, O’Donnell RT (2012) CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy. Cancer Res 72(21):5556-5565. doi: 10.1158/0008-5472.CAN-12-0173 Summary: The median overall survival of patients with advanced, unresectable, non-small cell lung cancer is 9-12 mos. […]
